Celcuity Inc. and Corcept Therapeutics are noted for developing targeted therapies in the United States.
1 report, 1 independent
Updated Jul 31
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Celcuity Inc. and Corcept Therapeutics are noted for developing targeted therapies in the United States.
Who's involved
What this event is mainly aboutHow it developed
Newest first. Tap a step to see who reported it.- Corcept Therapeutics is seeking final approval from the European Commission for a cancer therapy already approved in the US market.Sub-event
Both Celcuity and Corcept are developing targeted therapies in the US.1 source
Keep exploring
The entities involved
-
Corcept Therapeutics
American pharmaceutical company
Related events
Coverage
Newest first; wire copies grouped- Simply Wall St.Insiders Favor These 3 High Growth Companies Over the last 7 days, the United States market has remained flat, yet it has seen a 16% increase over the past year with earnings projected to grow by 15%